Skip to content

DMT: all studies

Page 119 of 160: studies 1,181 to 1,190 of 1,593, newest first. Back to the DMT overview

Research

(CASO CLÍNICO) UN MAL VIAJE CON AYAHUASCA: A PROPÓSITO DE UN CASO

Libro Comunicaciones 2021

Descripción del caso: Mujer de 30 años traída a Urgencias tras encontrarla andando por la carretera. Hace 48h se encontraba en un retiro espiritual, consumiendo una cantidad indeterminada de ayahuasca. Ha permanecido en vigilia desde el consumo, con sensación de que si acaba cerrando los ojos puede morir. Se encuentra inquieta, con desinhibición conductual y en contexto de elevada angustia, se...

LA AYAHUASCA COMO NUEVO HORIZONTE TERAPÉUTICO EN TRASTORNOS PSIQUIÁTRICOS

Libro Comunicaciones 2021

- Objetivos: Ayahuasca es una bebida compuesta por Banisteriopsis caapi, rica en β-carbolinas (harmina, tetrahidroharmina y harmalina) y Psychotria viridis, rica en dimetiltriptamina (DMT). β-carbolinas funcionan como inhibidores reversibles de la enzima monoaminooxidasa A, involucrada en la inhibición del metabolismo de DMT. DMT es un agonista parcial de los receptores de serotonina con...

Psychedelic Clinical Studies - Bibliometric Dataset

Figshare 2021 Jeremy Weleff, Teddy J. Akiki, Brian S. Barnett preprint

Dataset for a bibliometric analysis of journal articles reporting findings from clinical studies of the psychedelics 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT), ayahuasca, dimethyltryptamine (DMT), ibogaine, lysergic acid diethylamide (LSD), mescaline, MDMA, and psilocybin published from 1965-2018.This data accompanies our article:Bibliometric Analysis of Academic Journal Articles Reporting...

DOI: 10.6084/m9.figshare.17054405 (opens in new tab) Data science Information retrieval

1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Frontiers in Psychiatry 2021 Sylvana Vilca-Melendez, Malin V. Uthaug, Julian L Griffin 5 citations

While psychedelics may have therapeutic potential for treating mental health disorders such as depression, further research is needed to better understand their biological effects and mechanisms of action when considering the development of future novel therapy approaches. Psychedelic research could potentially benefit from the integration of metabonomics by proton nuclear magnetic resonance...

Cada jurema é uma jurema: Continuidade, rupturas e inovações em religiosidades no Brasil

Revista del CESLA International Latin American Studies Review December 31, 2020 Robson Savoldi, Rodrigo de Azeredo Grünewald 2 citations

No Brasil, algumas plantas, bebidas e religiosidades são chamadas de jurema. Desde o período colonial, se registra o uso ritual da jurema entre indígenas do Nordeste do Brasil. Além disso, a jurema emerge com novas feições em uma religiosidade chamada catimbó, encadeada a partir daqueles ritos, e a qual foi alcançada pela umbanda em meados do século XX. A umbanda se reatualizou em contato com o...

Discriminative Stimulus Effects of Substituted Tryptamines in Rats

ACS Pharmacology & Translational Science December 29, 2020 Michael B. Gatch, Adam C. Hoch, Theresa M. Carbonaro 13 citations

Novel synthetic compounds have been available for decades as quasi-legal alternatives to controlled substances. The hallucinogen-like effects of eight novel substituted tryptamines were evaluated to determine their potential abuse liability. Male Sprague-Dawley rats were trained to discriminate 2,5-dimethoxy-4-methylamphetamine (DOM, 0.5 mg/kg, i.p., 30 min) from saline....

DOI: 10.1021/acsptsci.0c00173 (opens in new tab) Full text (opens in new tab) Tryptamines Stimulus control Hallucinogen Abuse liability +3

Investigation of the Structure–Activity Relationships of Psilocybin Analogues

ACS Pharmacology & Translational Science December 14, 2020 Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski et al. 103 citations

The 5-HT2A receptor is thought to be the primary target for psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) and other serotonergic hallucinogens (psychedelic drugs). Although a large amount of experimental work has been conducted to characterize the pharmacology of psilocybin and its dephosphorylated metabolite psilocin (4-hydroxy-N,N-dimethyltryptamine), there has been little systematic...

Avaliação da variação morfológica, anatômica e fitoquímica de >i/i< (Spruce ex Griseb.) C.v. Morton e >i/i< Ruiz & Pav em diferentes ambientes, teor de alcaloides e citotoxicidade do chá Ayahuasca

December 10, 2020 Ordilena Ferreira de Miranda

\n B. caapi e P. viridis são plantas de origem amazônica e as principais espécies preconizados para preparação do chá Ayahuasca. Um chá com efeitos enteogênico e psicotrópico de uso milenar pelos povos indígenas da Amazônia, preparado pela decocção de caules de B. Caapi, que apresenta os alcaloides β-carbolínicos harmina (HRM), harmalina (HRL) e tetrahidrohramina (THH), e folhas de P. viridis...

Toxicology and Analysis of Psychoactive Tryptamines

International Journal of Molecular Sciences December 4, 2020 Sara Malaca, Alfredo Fabrizio Lo Faro, Alice Tamborra et al. 48 citations

Our understanding of tryptamines is poor due to the lack of data globally. Tryptamines currently are not part of typical toxicology testing regimens and their contribution to drug overdoses may be underestimated. Although their prevalence was low, it is increasing. There are few published data on the many new compounds, their mechanisms of action, onset and duration of action, toxicity, signs...

DOI: 10.3390/ijms21239279 (opens in new tab) Tryptamines Pharmacology Toxicology

Premier bilan des analyses toxicologiques effectuées dans le contexte du Drug Checking à Genève

December 1, 2020 Caroline Mathon, Christèle Widmer, R. Mégevand et al.

Objectif Depuis de nombreuses annees, la politique en matiere de drogues est basee en Suisse sur quatre piliers, a savoir la prevention, la therapie, la repression et la reduction des risques. Parmi les actions mises en œuvre concernant la reduction des risques lies aux consommations recreatives de substances psychoactives, une nouvelle offre a ete proposee depuis 2019 a Geneve, consistant en...